Short-Term and Long-Term Outcomes After Simultaneous Resection of Colorectal Malignancies and Synchronous Liver Metastases

被引:33
作者
de Santibanes, Eduardo [1 ,2 ]
Fernandez, Diego [1 ,2 ]
Vaccaro, Carlos [3 ]
Ojea Quintana, Guillermo [3 ]
Bonadeo, Fernando [3 ]
Pekolj, Juan [1 ,2 ]
Bonofiglio, Carlos [4 ]
Molmenti, Ernesto [5 ]
机构
[1] Hosp Italiano Buenos Aires, Hepato Pancreatobiliary Sect, Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Dept Gen Surg, Liver Transplant Sect, Buenos Aires, DF, Argentina
[3] Hosp Italiano Buenos Aires, Dept Gen Surg, Colorectal Sect, Buenos Aires, DF, Argentina
[4] Hosp Italiano Buenos Aires, Dept Anesthesia, Buenos Aires, DF, Argentina
[5] N Shore LIJ Hlth Syst, Dept Gen Surg, Great Neck, NY USA
关键词
Liver; Colorectal; Gastrointestinal; Oncology; Biliary; Critical care; POSITRON-EMISSION-TOMOGRAPHY; HEPATIC RESECTION; SURGICAL RESECTION; 1ST-LINE TREATMENT; NEOADJUVANT CHEMOTHERAPY; FLUOROURACIL-LEUCOVORIN; CARCINOMA METASTASES; CURATIVE SURGERY; RANDOMIZED-TRIAL; CANCER;
D O I
10.1007/s00268-010-0654-6
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
We evaluated the simultaneous resection of colorectal malignancies and synchronous liver metastases. Between June 1982 and June 2006, a total of 752 patients underwent resection of colorectal hepatic metastases. In all, 185 (25%) of them underwent simultaneous resection of the hepatic lesions and the corresponding primary tumors. The median hospital stay was 8 days (range 4-24 days), with a median operating time of 4 h (range 2-8 h). Altogether, 62 (33.5%) patients required intraoperative transfusion of packed red blood cells (median 2.1 IU, range 1-5 IU), and 25 (13.5%) were given frozen fresh plasma (median 2.1 IU, range 1-4 IU). The morbidity rate was 20.5%. There were two postoperative deaths (mortality rate 1.08%) within 30 days of the surgical intervention. Major hepatectomy was associated with greater morbidity (37.2% vs. 16.2%, P < 0.01) and mortality (4.7% vs. 0%, P < 0.05) rates. For the overall survivals (OS) at 3 and 5 years were 60.1% (52.3-67.85%) and 36.1% (27.4-44.8%), respectively. Disease-free survivals (DFS) at 3 and 5 years were 37.7% (30.2-45.3%) and 26.5% (18.7-34.3%), respectively. Transfusion of blood products, CEA level a parts per thousand yen 200 ng/dl, and N2 node status were found to be prognostic factors by univariate analysis. CEA level a parts per thousand yen 200 ng/dl and N2 node status achieved prognostic significance by multivariate analysis. The simultaneous resection of colorectal malignancies and synchronous liver metastases is safe, avoids an additional intervention, can be performed with low morbidity and mortality, and is associated with good oncologic outcomes. Node stage N2 and CEA level a parts per thousand yen 200 ng/dl should be given special consideration when selecting patients.
引用
收藏
页码:2133 / 2140
页数:8
相关论文
共 72 条
[1]
Colorectal cancer with synchronous liver metastases [J].
Adam, R. .
BRITISH JOURNAL OF SURGERY, 2007, 94 (02) :129-131
[2]
Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases [J].
Allen, PJ ;
Kemeny, N ;
Jarnagin, W ;
DeMatteo, R ;
Blumgart, L ;
Fong, Y .
JOURNAL OF GASTROINTESTINAL SURGERY, 2003, 7 (01) :109-115
[3]
[Anonymous], 2000, HPB, DOI DOI 10.1080/136518202760378489
[4]
Neoadjuvant treatment before resection of liver metastases [J].
Benoist, S. ;
Nordlinger, B. .
EJSO, 2007, 33 :S35-S41
[5]
CADY B, 1991, SEMIN ONCOL, V18, P399
[6]
Timing of resection of liver metastases synchronous to colorectal tumor: Proposal of prognosis-based decisional model [J].
Capussotti, Lorenzo ;
Vigano, Luca ;
Ferrero, Alessandro ;
Lo Tesoriere, Roberto ;
Ribero, Dario ;
Polastri, Roberto .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (03) :1143-1150
[7]
Major liver resections synchronous with colorectal surgery [J].
Capussotti, Lorenzo ;
Ferrero, Alessandro ;
Vigano, Luca ;
Ribero, Dario ;
Lo Tesoriere, Roberto ;
Polastri, Roberto .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) :195-201
[8]
Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases [J].
Chua, HK ;
Sondenaa, K ;
Tsiotos, GG ;
Larson, DR ;
Wolff, BG ;
Nagorney, DM .
DISEASES OF THE COLON & RECTUM, 2004, 47 (08) :1310-1316
[9]
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].
de Gramont, A ;
Figer, A ;
Seymour, M ;
Homerin, M ;
Hmissi, A ;
Cassidy, J ;
Boni, C ;
Cortes-Funes, H ;
Cervantes, A ;
Freyer, G ;
Papamichael, D ;
Le Bail, N ;
Louvet, C ;
Hendler, D ;
de Braud, F ;
Wilson, C ;
Morvan, F ;
Bonetti, A .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947
[10]
Simultaneous colorectal and hepatic resections for colorectal cancer:: Postoperative and longterm outcomes [J].
de Santibañes, E ;
Lassalle, FB ;
McCormack, L ;
Pekolj, J ;
Quintana, GO ;
Vaccaro, C ;
Benati, M .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2002, 195 (02) :196-202